Autism associated SHANK3 missense point mutations impact conformational fluctuations and protein turnover at synapses

  1. Michael Bucher
  2. Stephan Niebling
  3. Yuhao Han
  4. Dmitry Molodenskiy
  5. Fatemeh Hassani Nia
  6. Hans-Jürgen Kreienkamp
  7. Dmitri Svergun
  8. Eunjoon Kim
  9. Alla S Kostyukova
  10. Michael R Kreutz  Is a corresponding author
  11. Marina Mikhaylova  Is a corresponding author
  1. Humboldt-Universität zu Berlin, Institute of Biology, Germany
  2. European Molecular Biology Laboratory, Germany
  3. University Medical Centre Hamburg-Eppendorf, Germany
  4. Korea Advanced Institute of Science and Technology, Republic of Korea
  5. Washington State University, United States
  6. Leibniz-Institute for Neurobiology, Germany

Abstract

Members of the SH3- and ankyrin-rich repeat (SHANK) protein family are considered as master scaffolds of the post-synaptic density of glutamatergic synapses. Several missense mutations within the canonical SHANK3 isoform have been proposed as causative for the development of autism spectrum disorders (ASDs). However, there is a surprising paucity of data linking missense mutation-induced changes in protein structure and dynamics to the occurrence of ASD-related synaptic phenotypes. In this proof-of-principle study, we focus on two ASD-associated point mutations, both located within the same domain of SHANK3 and demonstrate that both mutant proteins indeed show distinct changes in secondary and tertiary structure as well as higher conformational fluctuations. Local and distal structural disturbances result in altered synaptic targeting and changes of protein turnover at synaptic sites in rat primary hippocampal neurons.

Data availability

All data generated or analysed during this study are included in the manuscript and supporting files.

The following data sets were generated

Article and author information

Author details

  1. Michael Bucher

    Optobiology, Humboldt-Universität zu Berlin, Institute of Biology, Berlin, Germany
    Competing interests
    The authors declare that no competing interests exist.
  2. Stephan Niebling

    Molecular Biophysics and High-Throughput Crystallization, European Molecular Biology Laboratory, Hamburg, Germany
    Competing interests
    The authors declare that no competing interests exist.
  3. Yuhao Han

    Optobiology, Humboldt-Universität zu Berlin, Institute of Biology, Berlin, Germany
    Competing interests
    The authors declare that no competing interests exist.
  4. Dmitry Molodenskiy

    Biological Small Angle Scattering, European Molecular Biology Laboratory, Hamburg, Germany
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-5954-4294
  5. Fatemeh Hassani Nia

    Institute for Human Genetics, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany
    Competing interests
    The authors declare that no competing interests exist.
  6. Hans-Jürgen Kreienkamp

    Institute for Human Genetics, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-8871-9970
  7. Dmitri Svergun

    Biological Small Angle Scattering, European Molecular Biology Laboratory, Hamburg, Germany
    Competing interests
    The authors declare that no competing interests exist.
  8. Eunjoon Kim

    Center for Synaptic Brain Dysfunctions, Korea Advanced Institute of Science and Technology, Daejeon, Republic of Korea
    Competing interests
    The authors declare that no competing interests exist.
  9. Alla S Kostyukova

    The Gene and Linda Voiland School of Chemical Engineering and Bioengineering, Washington State University, Pullman, United States
    Competing interests
    The authors declare that no competing interests exist.
  10. Michael R Kreutz

    RG Neuroplasticity, Leibniz-Institute for Neurobiology, Magdeburg, Germany
    For correspondence
    michael.kreutz@zmnh.uni-hamburg.de
    Competing interests
    The authors declare that no competing interests exist.
  11. Marina Mikhaylova

    Optobiology, Humboldt-Universität zu Berlin, Institute of Biology, Berlin, Germany
    For correspondence
    marina.mikhaylova@hu-berlin.de
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-7646-1346

Funding

Deutsche Forschungsgemeinschaft (MI1923/1-2)

  • Marina Mikhaylova

Deutsche Forschungsgemeinschaft (FOR2419 TP2)

  • Marina Mikhaylova

Deutsche Forschungsgemeinschaft (EXC-2049-390688087)

  • Marina Mikhaylova

Leibniz-Gemeinschaft (Neurotranslation)

  • Michael R Kreutz

Deutscher Akademischer Austauschdienst (Research Stays for University Academics and Scientists Award)

  • Alla S Kostyukova

Hamburg Landesforschungsförderung (LFF-FV76)

  • Marina Mikhaylova

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Ethics

Animal experimentation: All animal experiments were carried out in accordance with the European Communities Council Directive (2010/63/EU) and the Animal Welfare Law of the Federal Republic of Germany (Tierschutzgesetz der Bundesrepublik Deutschland, TierSchG) approved by the local authorities of the city-state Hamburg (Behörde für Gesundheit und Verbraucherschutz, Fachbereich Veterinärwesen) and the animal care committee of the University Medical Center Hamburg-Eppendorf.

Copyright

© 2021, Bucher et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 3,719
    views
  • 450
    downloads
  • 16
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Michael Bucher
  2. Stephan Niebling
  3. Yuhao Han
  4. Dmitry Molodenskiy
  5. Fatemeh Hassani Nia
  6. Hans-Jürgen Kreienkamp
  7. Dmitri Svergun
  8. Eunjoon Kim
  9. Alla S Kostyukova
  10. Michael R Kreutz
  11. Marina Mikhaylova
(2021)
Autism associated SHANK3 missense point mutations impact conformational fluctuations and protein turnover at synapses
eLife 10:e66165.
https://doi.org/10.7554/eLife.66165

Share this article

https://doi.org/10.7554/eLife.66165

Further reading

    1. Medicine
    2. Neuroscience
    LeYuan Gu, WeiHui Shao ... HongHai Zhang
    Research Article

    The advent of midazolam holds profound implications for modern clinical practice. The hypnotic and sedative effects of midazolam afford it broad clinical applicability. However, the specific mechanisms underlying the modulation of altered consciousness by midazolam remain elusive. Herein, using pharmacology, optogenetics, chemogenetics, fiber photometry, and gene knockdown, this in vivo research revealed the role of locus coeruleus (LC)-ventrolateral preoptic nucleus noradrenergic neural circuit in regulating midazolam-induced altered consciousness. This effect was mediated by α1 adrenergic receptors. Moreover, gamma-aminobutyric acid receptor type A (GABAA-R) represents a mechanistically crucial binding site in the LC for midazolam. These findings will provide novel insights into the neural circuit mechanisms underlying the recovery of consciousness after midazolam administration and will help guide the timing of clinical dosing and propose effective intervention targets for timely recovery from midazolam-induced loss of consciousness.

    1. Neuroscience
    Ana Maria Ichim, Harald Barzan ... Raul Cristian Muresan
    Review Article

    Gamma oscillations in brain activity (30–150 Hz) have been studied for over 80 years. Although in the past three decades significant progress has been made to try to understand their functional role, a definitive answer regarding their causal implication in perception, cognition, and behavior still lies ahead of us. Here, we first review the basic neural mechanisms that give rise to gamma oscillations and then focus on two main pillars of exploration. The first pillar examines the major theories regarding their functional role in information processing in the brain, also highlighting critical viewpoints. The second pillar reviews a novel research direction that proposes a therapeutic role for gamma oscillations, namely the gamma entrainment using sensory stimulation (GENUS). We extensively discuss both the positive findings and the issues regarding reproducibility of GENUS. Going beyond the functional and therapeutic role of gamma, we propose a third pillar of exploration, where gamma, generated endogenously by cortical circuits, is essential for maintenance of healthy circuit function. We propose that four classes of interneurons, namely those expressing parvalbumin (PV), vasointestinal peptide (VIP), somatostatin (SST), and nitric oxide synthase (NOS) take advantage of endogenous gamma to perform active vasomotor control that maintains homeostasis in the neuronal tissue. According to this hypothesis, which we call GAMER (GAmma MEdiated ciRcuit maintenance), gamma oscillations act as a ‘servicing’ rhythm that enables efficient translation of neural activity into vascular responses that are essential for optimal neurometabolic processes. GAMER is an extension of GENUS, where endogenous rather than entrained gamma plays a fundamental role. Finally, we propose several critical experiments to test the GAMER hypothesis.